Substituted 2-Azabicyclic Compounds as Orexin Receptor Modulators
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies lack effective modulators for the orexin receptor, which are crucial for treating various disorders related to sleep-wake cycles, emotional behavior, and metabolic regulation, as existing treatments often have limited efficacy or significant side effects.
Innovation Solution
Development of substituted 2-azabicyclic compounds that act as orexin receptor modulators, specifically designed to target orexin-1 and orexin-2 receptors, allowing for therapeutic intervention in disorders mediated by orexin receptor activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing treatments are used for orexin receptor-related disorders, then treatment can be provided, but efficacy is limited and significant side effects occur
Solution Approach 1:
The patent applies parameter changes by developing compounds with specific molecular structures (substituted 2-azabicyclic compounds with formulas I and II) that modify the pharmacological parameters of orexin receptor interaction. By changing the chemical structure parameters including specific substituents at defined positions, the invention achieves improved efficacy and reduced side effects compared to existing treatments
Solution Approach 2:
The patent segments the treatment approach by developing selective modulators for different orexin receptor subtypes (orexin-1 and orexin-2 receptors). The compounds are designed to selectively target specific receptors, allowing differentiated treatment strategies for different disorders based on which receptor subtype is primarily involved
2Reliability
If current therapies are used for sleep-wake cycle disorders, then treatment is available, but the treatments have limited efficacy
Solution Approach 1:
The patent applies universality by developing compounds that can treat multiple different disorders through orexin receptor modulation. The same class of compounds (substituted 2-azabicyclic compounds) is applicable to sleep-wake cycle disorders, emotional behavior disorders, and metabolic disorders, providing a universal therapeutic platform with broad adaptability
Data Source
AI summary
The present invention is directed to compounds of Formula (I): Methods of making the compounds of Formula I are also described. The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of using the compounds of the invention are also within the scope of the invention.